GILEAD SCIENCES, INC. Share-based Payment Arrangement, Expense, Tax Benefit
GILEAD SCIENCES, INC. (GILD) reported Share-based Payment Arrangement, Expense, Tax Benefit of $254.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-24
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-12-31 was $30.00M, a 87.50% increase year-over-year.
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-09-30 was $53.00M, a 194.44% increase year-over-year.
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-06-30 was $25.00M, a 127.27% increase year-over-year.
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-03-31 was $23.00M, a 21.05% increase year-over-year.
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $254.00M, a 32.29% increase from fiscal 2024.
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $192.00M, a 16.36% increase from fiscal 2023.
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $165.00M, a 81.32% increase from fiscal 2022.
- GILEAD SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $91.00M, a 9.00% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 3 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $254.00M 10-K · filed 2026-02-24 | |||||||
| 2024-12-31 | $192.00M 10-K · filed 2026-02-24 | |||||||
| 2023-12-31 | $165.00M 10-K · filed 2026-02-24 | |||||||
| 2022-12-31 | $91.00M 10-K · filed 2025-02-28 | |||||||
| 2021-12-31 | $100.00M 10-K · filed 2024-02-23 | |||||||
| 2020-12-31 | $222.00M 10-K · filed 2023-02-22 | |||||||
| 2019-12-31 | -$2.00M 10-K · filed 2022-02-23 | |||||||
| 2018-12-31 | $164.00M 10-K · filed 2021-02-25 | |||||||
| 2017-12-31 | $280.00M 10-K · filed 2020-02-25 | |||||||
| 2016-12-31 | $104.00M 10-K · filed 2019-02-26 | |||||||
| 2015-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $83.00M derived: sum of 2 quarters · filed 2018-02-27 | $108.00M derived: sum of 3 quarters · filed 2018-02-27 | $131.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $53.00M 10-Q · filed 2015-11-04 | $78.00M derived: sum of 2 quarters · filed 2015-11-04 | $101.00M 10-Q · filed 2015-11-04 | $117.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $25.00M 10-Q · filed 2015-08-05 | $48.00M 10-Q · filed 2015-08-05 | $64.00M derived: sum of 3 quarters · filed 2017-02-27 | $82.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $23.00M 10-Q · filed 2015-05-08 | $39.00M derived: sum of 2 quarters · filed 2017-02-27 | $57.00M derived: sum of 3 quarters · filed 2017-02-27 | $68.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $34.00M derived: sum of 2 quarters · filed 2017-02-27 | $45.00M derived: sum of 3 quarters · filed 2017-02-27 | $64.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $18.00M 10-Q · filed 2015-11-04 | $18.07M 10-Q · filed 2014-11-05 | $29.00M derived: sum of 2 quarters · filed 2015-11-04 | $48.00M 10-Q · filed 2015-11-04 | $48.10M 10-Q · filed 2014-11-05 | $67.04M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $11.00M 10-Q · filed 2015-08-05 | $10.93M 10-Q · filed 2014-08-04 | $30.00M 10-Q · filed 2015-08-05 | $30.02M 10-Q · filed 2014-08-04 | $49.04M derived: sum of 3 quarters · filed 2016-02-24 | $65.04M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $19.00M 10-Q · filed 2015-05-08 | $19.09M 10-Q · filed 2014-05-07 | $38.04M derived: sum of 2 quarters · filed 2016-02-24 | $54.04M derived: sum of 3 quarters · filed 2016-02-24 | $69.61M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $19.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $35.04M derived: sum of 2 quarters · filed 2016-02-24 | $50.61M derived: sum of 3 quarters · filed 2016-02-24 | $67.00M 10-K · filed 2016-02-24 | $66.91M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $16.00M 10-Q · filed 2014-11-05 | $31.57M derived: sum of 2 quarters · filed 2014-11-05 | $47.96M 10-Q · filed 2014-11-05 | $62.70M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $15.57M 10-Q · filed 2014-08-04 | $31.96M 10-Q · filed 2014-08-04 | $46.71M derived: sum of 3 quarters · filed 2015-02-25 | $61.73M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $16.39M 10-Q · filed 2014-05-07 | $31.13M derived: sum of 2 quarters · filed 2015-02-25 | $46.16M derived: sum of 3 quarters · filed 2015-02-25 | $59.32M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $14.75M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $29.77M derived: sum of 2 quarters · filed 2015-02-25 | $42.94M derived: sum of 3 quarters · filed 2015-02-25 | $56.00M 10-K · filed 2015-02-25 | $55.96M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $15.02M 10-Q · filed 2013-10-31 | $28.19M derived: sum of 2 quarters · filed 2013-10-31 | $41.25M 10-Q · filed 2013-10-31 | $52.21M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $13.17M 10-Q · filed 2013-08-01 | $26.23M 10-Q · filed 2013-08-01 | $37.19M derived: sum of 3 quarters · filed 2014-02-25 | $48.49M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $13.06M 10-Q · filed 2013-05-08 | $24.02M derived: sum of 2 quarters · filed 2014-02-25 | $35.32M derived: sum of 3 quarters · filed 2014-02-25 | $47.53M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $10.96M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $22.26M derived: sum of 2 quarters · filed 2014-02-25 | $34.47M derived: sum of 3 quarters · filed 2014-02-25 | $47.33M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $11.30M 10-Q · filed 2012-11-06 | $23.51M derived: sum of 2 quarters · filed 2012-11-06 | $36.37M 10-Q · filed 2012-11-06 | $48.63M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $12.21M 10-Q · filed 2012-08-01 | $25.07M 10-Q · filed 2012-08-01 | $37.33M derived: sum of 3 quarters · filed 2013-02-27 | $51.32M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $12.86M 10-Q · filed 2012-05-04 | $25.12M derived: sum of 2 quarters · filed 2013-02-27 | $39.11M derived: sum of 3 quarters · filed 2013-02-27 | $52.76M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $12.26M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $26.25M derived: sum of 2 quarters · filed 2013-02-27 | $39.90M derived: sum of 3 quarters · filed 2013-02-27 | $52.33M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $13.99M 10-Q · filed 2011-11-04 | $27.64M derived: sum of 2 quarters · filed 2011-11-04 | $40.07M 10-Q · filed 2011-11-04 | $49.09M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $13.65M 10-Q · filed 2011-08-05 | -$13.65M 10-Q · filed 2010-08-09 | $26.08M 10-Q · filed 2011-08-05 | -$26.08M 10-Q · filed 2010-08-09 | $35.10M derived: sum of 3 quarters · filed 2012-02-23 | $47.49M derived: sum of 4 quarters · filed 2012-02-23 | ||
| 2010-03-31 | $12.43M 10-Q · filed 2011-05-09 | $21.45M derived: sum of 2 quarters · filed 2012-02-23 | $33.84M derived: sum of 3 quarters · filed 2012-02-23 | $19.52M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $21.41M derived: sum of 2 quarters · filed 2012-02-23 | $7.09M derived: sum of 3 quarters · filed 2012-02-23 | $46.49M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $12.39M 10-Q · filed 2010-11-08 | -$1.93M derived: sum of 2 quarters · filed 2010-11-08 | $37.47M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | -$14.32M 10-Q · filed 2010-08-09 | -$25.08M 10-Q · filed 2010-08-09 | ||||||
| 2008-12-31 | $40.56M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |